Style | Citing Format |
---|---|
MLA | Asgarbeik S, et al.. "The Role of Errfi1+808T/G Polymorphism in Diabetic Nephropathy." International Journal of Molecular and Cellular Medicine, vol. 8, no. , 2019, pp. 49-55. |
APA | Asgarbeik S, Amoli MM, Enayati S, Bandarian F, Nasliesfahani E, Forouzanfar K, Razi F, Angaji SA (2019). The Role of Errfi1+808T/G Polymorphism in Diabetic Nephropathy. International Journal of Molecular and Cellular Medicine, 8(), 49-55. |
Chicago | Asgarbeik S, Amoli MM, Enayati S, Bandarian F, Nasliesfahani E, Forouzanfar K, Razi F, Angaji SA. "The Role of Errfi1+808T/G Polymorphism in Diabetic Nephropathy." International Journal of Molecular and Cellular Medicine 8, no. (2019): 49-55. |
Harvard | Asgarbeik S et al. (2019) 'The Role of Errfi1+808T/G Polymorphism in Diabetic Nephropathy', International Journal of Molecular and Cellular Medicine, 8(), pp. 49-55. |
Vancouver | Asgarbeik S, Amoli MM, Enayati S, Bandarian F, Nasliesfahani E, Forouzanfar K, et al.. The Role of Errfi1+808T/G Polymorphism in Diabetic Nephropathy. International Journal of Molecular and Cellular Medicine. 2019;8():49-55. |
BibTex | @article{ author = {Asgarbeik S and Amoli MM and Enayati S and Bandarian F and Nasliesfahani E and Forouzanfar K and Razi F and Angaji SA}, title = {The Role of Errfi1+808T/G Polymorphism in Diabetic Nephropathy}, journal = {International Journal of Molecular and Cellular Medicine}, volume = {8}, number = {}, pages = {49-55}, year = {2019} } |
RIS | TY - JOUR AU - Asgarbeik S AU - Amoli MM AU - Enayati S AU - Bandarian F AU - Nasliesfahani E AU - Forouzanfar K AU - Razi F AU - Angaji SA TI - The Role of Errfi1+808T/G Polymorphism in Diabetic Nephropathy JO - International Journal of Molecular and Cellular Medicine VL - 8 IS - SP - 49 EP - 55 PY - 2019 ER - |